Lei Miao

机构：Peking University, State Key Laboratory of Natural and Biomimetic Drugs · ORCID：0009-0004-1647-1445

发表论文 49 篇 · 总被引 5565 次 · h-index 23

代表论文

• mRNA vaccine for cancer immunotherapy (2021 · Molecular Cancer · 被引 927)
• Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy (2020 · Science Translational Medicine · 被引 197)
• RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment (2024 · Nature Communications · 被引 38)
• Peptide codes for organ-selective mRNA delivery (2025 · Nature Materials · 被引 29)
• Enhancing mRNA translation efficiency by introducing sequence optimized AU-rich elements in 3′ UTR via HuR anchorage (2025 · Molecular Therapy — Nucleic Acids · 被引 28)
• Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury (2025 · Nature Communications · 被引 24)